MyFinsight
Home
Blog
About
Contact
Sales and maturities
of marketable...
$30,455K
Net cash provided by
investing activities
$20,234K
Canceled cashflow
$10,221K
Net change in cash,
cash equivalents and...
-$30,817K
Canceled cashflow
$20,234K
Stock-based compensation
$2,563K
Intangible asset
amortization
$1,987K
Accounts payable and
other liabilities
$1,480K
Right-of-use asset
amortization
$1,267K
Inventory
-$294K
Other non-cash
adjustments, net
-$280K
Depreciation of property and
equipment
$273K
Acquisition of intangible
asset
$10,000K
Purchases of property and
equipment
$221K
Net cash used in
operating activities
-$50,218K
Canceled cashflow
$8,144K
Net cash used in
financing activities
-$776K
Effect of exchange rate
changes on cash, cash...
-$57K
Net loss
-$48,567K
Prepaid expenses and
other assets
$5,768K
Accounts receivable
$2,333K
Product revenue
allowances
-$1,558K
Amortization of premiums and
accretion of discounts on...
$136K
Principal payments on
finance leases
$776K
Back
Back
Cash Flow
Vanda Pharmaceuticals Inc. (VNDA)
Vanda Pharmaceuticals Inc. (VNDA)
source: myfinsight.com